| 885 | 15 | 73 |
| 下载次数 | 被引频次 | 阅读次数 |
甲型和乙型流感病毒(Influenza A and B viruses, IAV, IBV)作为季节性流感的主要病原体，在人和动物中流行可造成较高的发病率和死亡率。目前，接种疫苗仍然是预防和控制流感最有效的方法。流感疫苗接种主要是诱导产生病毒中和抗体来抵抗流行毒株对机体的侵染。随着对流感病毒与机体免疫系统研究的不断深入，特异性T细胞免疫反应在预防流感病毒侵染机体过程中发挥的作用越来越被学者所关注。因此，明确机体特异性CD4+和CD8~+T细胞抗流感病毒侵染的作用机制，并了解对其作用有影响的各种因素，这将有助于科研人员在流感疫苗设计过程中更加兼顾新型疫苗在激活特异性T细胞反应性能上的提升，为设计出可诱导强大、广谱而持久免疫活性的新型流感疫苗提供依据。
Abstract：Serving as the important pathogens for seasonal influenza, influenza A virus(IAV) and IBV pose threats to public health and result in morbidity and mortality at high levels. Up to date, vaccine strategy remains the most effective way to prevent and control influenza infection. Previously, the main target of designing vaccine just aimed at the strong induction of specific neutralizing antibodies against influenza virus. Following the deep research on the interplay between influenza virus and immune system, more and more evidences showed that specific T cell responses played the important roles in antiviral activities against influenza infection. Thus, determining the mechanisms of T cell responses from CD4+ and CD8+ T cells induced by between natural infection and vaccine of influenza virus will provide new insights into the design of novel vaccine that can strongly stimulate the antiviral responses of CD4+ and CD8+ T cells.
[1] Hutchinson EC. Influenza Virus[J]. Trends Microbiol,2018, 26(9):809-810. DOI:10.1016/j.tim.2018.05.013.
[2] Henry C, Palm AE, Krammer F, et al. From Original Antigenic Sin to the Universal Influenza Virus Vaccine[J]. Trends Immunol, 2018, 39(1):70-79. DOI:10.1016/j.it.2017.08.003.
[3] Nachbagauer R, Palese P. Is a Universal Influenza Virus Vaccine Possible?[J]. Annu Rev Med, 2020, 71:315-327. DOI:10.1146/annurev-med-120617-041310.
[4] Lee CD, Watanabe Y, Wu NC, et al. A crossneutralizing antibody between HIV-1 and influenza virus[J]. PLoS Pathog, 2021, 17(3):e1009407. DOI:10.1371/journal.ppat.1009407.
[5] Wu NC, Wilson IA. Influenza Hemagglutinin Structures and Antibody Recognition[J]. Cold Spring Harb Perspect Med, 2020, 10(8):a038778. DOI:10.1101/cshperspect.a038778.
[6] Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol[J].Proc Natl Acad Sci U S A, 2017, 114(2):206-214.DOI:10.1073/pnas.1617020114.
[7] Prachanronarong KL, Canale AS, Liu P, et al.Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody[J]. J Virol,2019, 93(2):e01639-18. DOI:10.1128/jvi.01639-18.
[8] Jansen JM, Gerlach T, Elbahesh H, et al. Influenza virus-specific CD4+and CD8+T cell-mediated immunity induced by infection and vaccination[J]. J Clin Virol, 2019, 119:44-52. DOI:10.1016/j.jcv.2019.08.009.
[9] Mueller SN, Gebhardt T, Carbone FR, et al. Memory T cell subsets, migration patterns, and tissue residence[J]. Annu Rev Immunol, 2013, 31:137-61. DOI:10.1146/annurev-immunol-032712-095954.
[10]Hufford MM, Kim TS, Sun J, et al. The effector T cell response to influenza infection[J]. Curr Top Microbiol Immunol, 2015, 386:423-55. DOI:10.1007/82_2014_397.
[11]Jameson S C, Masopust D. Understanding Subset Diversity in T Cell Memory[J]. Immunity, 2018, 48(2):214-226. DOI:10.1016/j.immuni.2018.02.010.
[12]Tsang TK, Lam KT, Liu Y, et al. Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study[J]. BMC Med,2022, 20(1):230. DOI:10.1186/s12916-022-02429-7.
[13]Juno JA, van Bockel D, Kent SJ, et al. Cytotoxic CD4T Cells-Friend or Foe during Viral Infection?[J].Front Immunol, 2017, 8:19. DOI:10.3389/fimmu.2017.00019.
[14]Spitaels J, Roose K, Saelens X. Influenza and Memory T Cells:How to Awake the Force[J]. Vaccines(Basel), 2016, 4(4):33. DOI:10.3390/vaccines4040033.
[15]Takeuchi A, Saito T. CD4 CTL, a Cytotoxic Subset of CD4(+)T Cells, Their Differentiation and Function[J]. Front Immunol, 2017, 8:194. DOI:10.3389/fimmu.2017.00194.
[16]Prigge AD, Ma R, Coates BM, et al. Age-Dependent Differences in T-Cell Responses to Influenza A Virus[J]. Am J Respir Cell Mol Biol, 2020, 63(4):415-423.DOI:10.1165/rcmb.2020-0169TR.
[17]Nelson SA, Dileepan T, Rasley A, et al. Intranasal Nanoparticle Vaccination Elicits a Persistent,Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge[J]. J Virol, 2021, 95(16):e0084121. DOI:10.1128/jvi.00841-21.
[18]Nayak JL, Richards KA, Yang H, et al. Effect of influenza A(H5N1)vaccine prepandemic priming on CD4+T-cell responses[J]. J Infect Dis, 2015, 211(9):1408-1417. DOI:10.1093/infdis/jiu616.
[19]Lu Y, Jiang R, Freyn AW, et al. CD4+follicular regulatory T cells optimize the influenza virus-specific B cell response[J]. J Exp Med, 2021, 218(3):e20200547.DOI:10.1084/jem.20200547.
[20]Heit A, Schmitz F, Gerdts S, et al. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans[J]. J Exp Med, 2017, 214(7):2139-2152. DOI:10.1084/jem.20161794.
[21]Herati RS, Muselman A, Vella L, et al. Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells[J]. Sci Immunol, 2017, 2(8):eaag2152. DOI:10.1126/sciimmunol.aag2152.
[22]Sant AJ, Richards KA, Nayak J. Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus[J]. Curr Opin Immunol,2018, 53:13-21. DOI:10.1016/j.coi.2018.03.019.
[23]Clemens EB, van de Sandt C, Wong SS, et al.Harnessing the Power of T Cells:The Promising Hope for a Universal Influenza Vaccine[J]. Vaccines(Basel), 2018, 6(2):18. DOI:10.3390/vaccines6020018.
[24]Wu CY, Chuang HY, Wong CH. Influenza virus neuraminidase regulates host CD8(+)T-cell response in mice[J]. Commun Biol, 2020, 3(1):748. DOI:10.1038/s42003-020-01486-z.
[25]Liu X, Zhao T, Wang L, et al. Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine[J]. Front Microbiol, 2022, 13:1014122.DOI:10.3389/fmicb.2022.1014122.
[26]Welten SPM, Oderbolz J, Yilmaz V, et al. Influenzaand MCMV-induced memory CD8 T cells control respiratory vaccinia virus infection despite residence in distinct anatomical niches[J]. Mucosal Immunol, 2021,14(3):728-742. DOI:10.1038/s41385-020-00373-4.
[27]Jenkins MM, Bachus H, Botta D, et al. Lung dendritic cells migrate to the spleen to prime long-lived TCF1(hi)memory CD8(+)T cell precursors after influenza infection[J]. Sci Immunol, 2021, 6(63):eabg6895.DOI:10.1126/sciimmunol.abg6895.
[28]Reilly EC, Sportiello M, Emo KL, et al. CD49a Identifies Polyfunctional Memory CD8 T Cell Subsets that Persist in the Lungs After Influenza Infection[J].Front Immunol, 2021,12:728669. DOI:10.3389/fimmu.2021.728669.
[29]Matyushenko V, Kotomina T, Kudryavtsev I, et al.Conserved T-cell epitopes of respiratory syncytial virus(RSV)delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenzaspecific resident memory T-cell responses[J]. Antiviral Res, 2020, 182:104864. DOI:10.1016/j.antiviral.2020.104864.
[30]Son YM, Cheon IS, Wu Y, et al. Tissue-resident CD4(+)T helper cells assist the development of protective respiratory B and CD8(+)T cell memory responses[J]. Sci Immunol, 2021, 6(55):eabb6852. DOI:10.1126/sciimmunol.abb6852.
[31]Uddb?ck I, Kohlmeier JE, Thomsen AR, et al.Harnessing Cross-Reactive CD8(+)T(RM)Cells for Long-Standing Protection Against Influenza A Virus[J]. Viral Immunol, 2020, 33(3):201-207. DOI:10.1089/vim.2019.0177.
[32]Goplen NP, Wu Y, Son YM, et al. Tissue-resident CD8(+)T cells drive age-associated chronic lung sequelae after viral pneumonia[J]. Sci Immunol, 2020,5(53):eabc4557. DOI:10.1126/sciimmunol.abc4557.
[33]Slütter B, Van Braeckel-Budimir N, Abboud G, et al.Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity[J]. Sci Immunol, 2017, 2(7):eaag2031. DOI:10.1126/sciimmunol.aag2031.
[34]Zhou AC, Batista NV, Watts TH. 4-1Regulates Effector CDBB8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and AntigenDependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection[J]. J Immunol, 2019, 202(8):2482-2492.DOI:10.4049/jimmunol.1800795.
[35]Goplen NP, Huang S, Zhu B, et al. Tissue-Resident Macrophages Limit Pulmonary CD8 Resident Memory T Cell Establishment[J]. Front Immunol, 2019, 10:2332. DOI:10.3389/fimmu.2019.02332.
[36]Agrawal K, Ong LC, Monkley S, et al. Allergic sensitization impairs lung resident memory CD8 T-cell response and virus clearance[J]. J Allergy Clin Immunol, 2022, 150(6):1415-1426. DOI:10.1016/j.jaci.2022.07.004.
[37]Pizzolla A, Nguyen TH, Sant S, et al. Influenzaspecific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles[J]. J Clin Invest, 2018, 128(2):721-733. DOI:10.1172/jci96957.
[38]Knight FC, Wilson JT. Engineering Vaccines for Tissue-Resident Memory T Cells[J]. Adv Ther(Weinh), 2021, 4(4):2000230. DOI:10.1002/adtp.202000230.
[39]Lee W, Kingstad-Bakke B, Kedl RM, et al. CCR2Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus[J]. J Virol, 2021, 95(15):e0053021. DOI:10.1128/jvi.00530-21.
[40]Matyushenko V, Kotomina T, Kudryavtsev I, et al.Conserved T-cell epitopes of respiratory syncytial virus(RSV)delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenzaspecific resident memory T-cell responses[J]. Antiviral Res, 2020, 182:104864. DOI:10.1016/j.antiviral.2020.104864.
[41]Isakova-Sivak I, Stepanova E, Mezhenskaya D, et al.Influenza vaccine:progress in a vaccine that elicits a broad immune response[J]. Expert Rev Vaccines,2021, 20(9):1097-1112. DOI:10.1080/14760584.2021.1964961.
[42]Schmidt A, Lapuente D. T Cell Immunity against Influenza:The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine[J].Viruses, 2021, 13(2):199. DOI:10.3390/v13020199.
[43]Bedford JG, Caminschi I, Wakim LM. Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8(+)T Cells That Are Protective against Influenza Virus Infection[J].Vaccines(Basel), 2020, 8(4):572. DOI:10.3390/vaccines8040572.
[44]Uddb?ck I, Cartwright EK, Sch?ller AS, et al. Longterm maintenance of lung resident memory T cells is mediated by persistent antigen[J]. Mucosal Immunol,2021, 14(1):92-99. DOI:10.1038/s41385-020-0309-3.
[45]Marinaik CB, Kingstad-Bakke B, Lee W, et al.Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants[J]. Cell Rep Med, 2020, 1(6):100095. DOI:10.1016/j.xcrm.2020.100095.
[46]MacKerracher A, Sommershof A, Groettrup M. PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection[J]. Eur J Pharm Sci, 2022, 175:106209. DOI:10.1016/j.ejps.2022.106209.
[47]Knight FC, Gilchuk P, Kumar A, et al. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8(+)Lung-Resident Memory T Cells[J]. ACS Nano, 2019, 13(10):10939-10960. DOI:10.1021/acsnano.9b00326.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.004422
中图分类号:R373
引用信息:
[1]杨宣叶,胡欣妍,高明阳,等.CD4~+和CD8~+ T细胞在抗流感病毒免疫中的重要作用[J].病毒学报,2024,40(01):206-214.DOI:10.13242/j.cnki.bingduxuebao.004422.
基金信息:
中央高校基本科研业务费专项资金资助（NO.31920220134）,题目：牛病毒性腹泻病毒抗原表位的筛选及应用; 甘肃省自然科学基金（20JR5RA505）,题目：Atg13蛋白通过激活RLR/MAVS介导的IFN-β信号通路~~
2023-11-21
2023-11-21
2023-11-21